Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial

in response to

Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial

BearDownAZ

posted on Sep 02, 2018 01:11PM

As I said on the Bioasis Hub...

"Sweet deal for Denali, right out of the gate going NASDAQ with an IPO and a collaboration with a multi-billion dollar pharma............ The right formula for Zenith."

Zenith needs to go NASDAQ.

Koo

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply